Blog
RSS FeedPosted by Michael Wonder on 09 May 2022
Choices that fail health and wellbeing
5 May 2022 - NICE's expert group RAPID C-19, set up to ‘to ensure safe and timely patient access to treatments ...
Posted by Michael Wonder on 05 Feb 2020
NICE plans to widen the net for data it uses in guidance
5 February 2020 - UK cost-effectiveness body NICE has said it intends to use a broader range of data and ...
Posted by Michael Wonder on 04 Feb 2020
Broader types of data to be used in development of NICE guidance
4 February 2020 - An expanded evidence base could allow NICE to address evidence gaps and enhance reviews of the impact ...
Posted by Michael Wonder on 03 Jan 2020
Additional evidence needed to assess histology-independent cancer drugs says paper co-authored by NICE staff
2 January 2020 - Paper looks at how histology-independent cancer drugs might be appraised. ...
Posted by Michael Wonder on 29 Jun 2019
NICE explores extending its use of data to inform its guidance
25 June 2019 - NICE has revised its earlier press release on the use of real world data to inform ...
Posted by Michael Wonder on 26 Sep 2018
Quality assurance of registries for health technology assessment
25 September 2018 - The aim of this study was to identify guidelines and assessment tools used by health technology agencies ...
Posted by Michael Wonder on 20 Sep 2018
Using evidence from randomised controlled trials in economic models: what information is relevant and is there a minimum amount of sample data required to make decisions?
21 September 2018 - Evidence from randomised controlled trials is used to support regulatory approval and reimbursement decisions. ...
Posted by Michael Wonder on 24 Jul 2018
Assessing the value of innovative devices and diagnostics: the importance of clear and relevant claims of benefit
20 July 2018 - Large numbers of new medical devices and diagnostics are developed and health services need to identify which ...
Posted by Michael Wonder on 24 Oct 2017
Can ad hoc analyses of clinical trials help personalise treatment decisions?
23 October 2017 - The value of ad hoc analyses of clinical trials may not be clear. Ad hoc analyses are ...
Posted by Michael Wonder on 17 Sep 2017
Multivariate and network meta-analysis of multiple outcomes and multiple treatments: rationale, concepts, and examples
13 September 2017 - Organisations such as the NICE require the synthesis of evidence from existing studies to inform their decisions—for ...